Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

What is Genetic Engineering?00:49

What is Genetic Engineering?

Overview
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
Transgenic Organisms00:53

Transgenic Organisms

Overview
Transgenic Organisms00:53

Transgenic Organisms

Overview
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Transgenic Plants02:50

Transgenic Plants

Recombinant DNA technology called transgenesis is often used to add a foreign gene or remove a detrimental gene from an organism. Such genetically modified organisms are called transgenic organisms.
The first-ever transgenic plant was a tobacco plant developed in 1983 that showed resistance against the tobacco mosaic virus. Since then, many transgenic plants have been developed and commercialized for improving the agricultural, ornamental, and horticultural value of a crop plant. Transgenic...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Antipsychotic Drugs and the Risk of Diabetic Complications: A Systematic Review of Observational Studies.

Journal of clinical medicine·2026
Same author

Understanding how adverse childhood experiences influence the development of postpartum post-traumatic stress disorder: a qualitative study in China.

European journal of psychotraumatology·2026
Same author

Antipsychotic Drugs and the Risk of Diabetic Complications: A Systematic Review of Clinical Evidence.

Journal of clinical medicine·2026
Same author

Effects of vaginal microbiota transfer on social-emotional and neurodevelopment in cesarean-born infants: 12-month follow-up of a pilot randomized clinical trial.

Acta obstetricia et gynecologica Scandinavica·2026
Same author

Self-perceived mental health among Canadian adolescents and young adults with asthma: Insights from a national cross-sectional study.

The Journal of asthma : official journal of the Association for the Care of Asthma·2026
Same author

Trends in Antipsychotic Drug Use in the United States, 2000-2016.

Pharmacy (Basel, Switzerland)·2026

Related Experiment Video

Updated: Jul 1, 2026

Preventing the Spread of Malaria and Dengue Fever Using Genetically Modified Mosquitoes
17:50

Preventing the Spread of Malaria and Dengue Fever Using Genetically Modified Mosquitoes

Published on: July 4, 2007

A risk-based classification scheme for genetically modified foods. I: Conceptual development.

Eunice Chao1, Daniel Krewski

  • 1McLaughlin Centre for Population Health Risk Assessment, Institute of Population Health, University of Ottawa, 1 Stewart Street, Ottawa, Ont., Canada KIN 6N5. echao@uottawa.ca

Regulatory Toxicology and Pharmacology : RTP
|September 10, 2008
PubMed
Summary
This summary is machine-generated.

A new risk-based classification scheme (RBCS) for genetically modified (GM) foods evaluates potential health risks, focusing on toxic and allergenic effects. This approach aims to guide regulatory oversight for GM food safety assessments.

More Related Videos

Quantification of the Potential Impact of Glyphosate-Based Products on Microbiomes
07:42

Quantification of the Potential Impact of Glyphosate-Based Products on Microbiomes

Published on: January 10, 2022

A Protocol for Genetic Induction and Visualization of Benign and Invasive Tumors in Cephalic Complexes of Drosophila melanogaster
07:23

A Protocol for Genetic Induction and Visualization of Benign and Invasive Tumors in Cephalic Complexes of Drosophila melanogaster

Published on: September 11, 2013

Related Experiment Videos

Last Updated: Jul 1, 2026

Preventing the Spread of Malaria and Dengue Fever Using Genetically Modified Mosquitoes
17:50

Preventing the Spread of Malaria and Dengue Fever Using Genetically Modified Mosquitoes

Published on: July 4, 2007

Quantification of the Potential Impact of Glyphosate-Based Products on Microbiomes
07:42

Quantification of the Potential Impact of Glyphosate-Based Products on Microbiomes

Published on: January 10, 2022

A Protocol for Genetic Induction and Visualization of Benign and Invasive Tumors in Cephalic Complexes of Drosophila melanogaster
07:23

A Protocol for Genetic Induction and Visualization of Benign and Invasive Tumors in Cephalic Complexes of Drosophila melanogaster

Published on: September 11, 2013

Area of Science:

  • Food safety assessment
  • Genetically modified organisms (GMOs)
  • Toxicology and allergy

Background:

  • Current GM food safety assessments primarily focus on recombinant DNA (rDNA) techniques.
  • Foods modified by other genetic modification methods often bypass rigorous safety evaluations.
  • Public concern necessitates a more comprehensive approach to GM food regulation.

Purpose of the Study:

  • To develop and evaluate a risk-based classification scheme (RBCS) for crop-derived GM foods.
  • To determine appropriate regulatory oversight and testing levels for GM products.
  • To address potential adverse health effects, including toxic, antinutritional, and allergenic concerns.

Main Methods:

  • Identification of factors influencing potential health risks in GM foods.
  • Development of criteria to differentiate health risk potential for each factor.
  • Rating the extent to which a GM food meets applicable risk criteria.
  • Aggregation of factor ratings using predefined rules to determine concern levels for toxicological and allergenic effects.

Main Results:

  • A conceptual framework for the proposed RBCS has been developed.
  • The scheme focuses on differentiating health risks based on specific factors and criteria.
  • A hypothetical GM food was used to demonstrate the application of the RBCS.

Conclusions:

  • The proposed RBCS offers a structured approach to assessing GM food safety.
  • This risk-based framework can inform regulatory decisions for GM foods beyond rDNA techniques.
  • Further application and validation of the RBCS are warranted for comprehensive GM food safety evaluation.